Therefore, the result indicated that the overall expression level of the mucin family was negatively correlated with the prognosis of patients with pancreatic cancer, which means that we can determine the prognosis and survival of patients by detecting the expression of mucin in clinical work (Fig 2). The gene discussed is MUC5AC; the disease is familial pancreatic carcinoma.